Leerink Swann Starts Onconova Therapeutics (ONTX) at Outperform
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Citi Starts Onconova Therapeutics (ONTX) at Neutral
August 19, 2013 6:54 AM EDTCiti initiates coverage on Onconova Therapeutics (NASDAQ: ONTX) with a Neutral. PT $30.00.
For an analyst ratings summary and ratings history on Onconova Therapeutics click here. For more ratings news on Onconova Therapeutics click here.
Shares of Onconova Therapeutics closed at $25.69 yesterday, with a 52 week range of $19.42-$30.00.... More
Janney Starts Onconova Therapeutics (ONTX) at Buy
August 19, 2013 6:53 AM EDTJanney Montgomery Scott initiates coverage on Onconova Therapeutics (NASDAQ: ONTX) with a Buy. PT $40.00.
For an analyst ratings summary and ratings history on Onconova Therapeutics click here. For more ratings news on Onconova Therapeutics click here.
Shares of Onconova Therapeutics closed at $25.69 yesterday, with a 52 week range of $19.42-$30.00.... More
Piper Jaffray Starts Onconova Therapeutics (ONTX) at Overweight
August 19, 2013 6:51 AM EDTPiper Jaffray initiates coverage on Onconova Therapeutics (NASDAQ: ONTX) with a Overweight. PT $38.00.
For an analyst ratings summary and ratings history on Onconova Therapeutics click here. For more ratings news on Onconova Therapeutics click here.
Shares of Onconova Therapeutics closed at $25.69 yesterday, with a 52 week range of $19.42-$30.00.... More